Guidelines for the experimental design of pharmacokinetic studies with nanomaterials in preclinical animal models
Authors:
- 1 July 2020
- journal article
- research article
- Published by Elsevier in Journal of Controlled Release
- Vol. 323, 83-101
Abstract
No abstract availableKeywords
Funding Information
- Terry Fox Research Institute
This publication has 115 references indexed in Scilit:
- Correlating preclinical animal studies and human clinical trials of a multifunctional, polymeric nanoparticleProceedings of the National Academy of Sciences, 2013
- Nanoparticle clearance is governed by Th1/Th2 immunity and strain backgroundJournal of Clinical Investigation, 2013
- Design of polymeric nanoparticles for biomedical delivery applicationsChemical Society Reviews, 2012
- Image Guided Biodistribution and Pharmacokinetic Studies of TheranosticsTheranostics, 2012
- Anti-PEG IgM Response against PEGylated Liposomes in Mice and RatsPharmaceutics, 2010
- Blood sample collection in small laboratory animalsJournal of Pharmacology and Pharmacotherapeutics, 2010
- Intraperitoneal Therapy for Peritoneal CancerFuture Oncology, 2010
- Translational considerations for cancer nanomedicineJournal of Controlled Release, 2010
- Estimation of the 18F-FDG Input Function in Mice by Use of Dynamic Small-Animal PET and Minimal Blood Sample DataJournal of Nuclear Medicine, 2007
- The Phenomenon and Rationale of Marked Dependence of Drug Concentration on Blood Sampling SiteClinical Pharmacokinetics, 1989